Market Overview

APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS)

47.22 -0.24 (-0.51%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/23/20CitigroupMaintainsBuy67.0
11/19/20NeedhamInitiates Coverage OnBuy59.0
9/01/20StifelInitiates Coverage OnBuy40.0
7/20/20Roth CapitalInitiates Coverage OnBuy50.0
6/30/20CitigroupMaintainsBuy54.0
6/17/20BTIGInitiates Coverage OnNeutral
6/08/20JP MorganMaintainsOverweight56.0
4/28/20Cantor FitzgeraldMaintainsOverweight61.0
4/01/20Raymond JamesInitiates Coverage OnStrong Buy86.0
3/31/20BMO CapitalInitiates Coverage OnOutperform54.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter